Camille Brugere-Chakiba

Bordeaux, 33076, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Breast cryoablation for small, low-risk breast cancers: Current evidence, practical integration, and future directions.

Breast cryoablation for small, low-risk breast cancers: Current evidence, practical integration, and future directions.

Journal: Diagnostic and interventional imaging

Published: April 20, 2026

Current challenges in geriatric oncology

Current challenges in geriatric oncology

Journal: La Revue du praticien

Published: February 23, 2026

Real-world feasibility of first-line palbociclib for hormone receptor-positive HER2-negative locally advanced/metastatic breast cancer in women aged 70 years and older - final results of the endocrine-sensitive cohort in the French prospective non-interventional PalomAGE study.

Real-world feasibility of first-line palbociclib for hormone receptor-positive HER2-negative locally advanced/metastatic breast cancer in women aged 70 years and older - final results of the endocrine-sensitive cohort in the French prospective non-interventional PalomAGE study.

Journal: Breast (Edinburgh, Scotland)

Published: November 27, 2025

Palbociclib plus letrozole versus weekly paclitaxel, both in combination with trastuzumab plus pertuzumab, as neoadjuvant treatment for patients with HR-positive/HER2-positive early breast cancer: primary results from the randomized phase II TOUCH trial (IBCSG 55-17).

Palbociclib plus letrozole versus weekly paclitaxel, both in combination with trastuzumab plus pertuzumab, as neoadjuvant treatment for patients with HR-positive/HER2-positive early breast cancer: primary results from the randomized phase II TOUCH trial (IBCSG 55-17).

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: June 05, 2025

Important aspects of care and priorities of older patients with cancer: The PRIORITY multicenter cohort study.

Important aspects of care and priorities of older patients with cancer: The PRIORITY multicenter cohort study.

Journal: Journal of geriatric oncology

Published: May 06, 2025

Combination of Olaparib, Durvalumab, and Fulvestrant in Patients with Advanced ER+/HER2- Breast Cancer and Selected Genomic Alterations: Results of the DOLAF Trial.

Combination of Olaparib, Durvalumab, and Fulvestrant in Patients with Advanced ER+/HER2- Breast Cancer and Selected Genomic Alterations: Results of the DOLAF Trial.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: December 20, 2024

Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in gBRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer.

Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in gBRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: February 01, 2024

One-Year Follow-Up of Seroprevalence of SARS-CoV-2 Infection and Anxiety among Health Workers of a French Cancer Center: The PRO-SERO-COV Study.

One-Year Follow-Up of Seroprevalence of SARS-CoV-2 Infection and Anxiety among Health Workers of a French Cancer Center: The PRO-SERO-COV Study.

Journal: International journal of environmental research and public health

Published: March 29, 2023

Adenosquamous Carcinoma of the Pancreas.

Adenosquamous Carcinoma of the Pancreas.

Journal: Clinical Medicine Insights. Oncology

Published: March 28, 2019

Showing 1-9 of 9

Last Updated: 09/26/2026